The association between patient and disease characteristics, and the risk of disease progression in patients with prostate cancer on active surveillance-Reference-Cited by-同舟云学术

The association between patient and disease characteristics, and the risk of disease progression in patients with prostate cancer on active surveillance

Published:2024-02-19 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Duijn Matthijs^ORCID,de Reijke Theo M.,Barwari Kurdo,Hagens Marias J.,Rynja Sybren P.,Immerzeel Jos,Barentsz Jelle O.,Jager Auke

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-04805-9.pdf

Reference20 articles.

1. Mohler JL, Antonarakis ES, Armstrong AJ et al (2019) Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 17(5):479–505

2. Kinsella N, Helleman J, Bruinsma S et al (2018) Active surveillance for prostate cancer: A systematic review of contemporary worldwide practices. Transl Androl Urol 7(1):83–97

3. Yao SL, Grace LY (2002) Understanding and appreciating overdiagnosis in the PSA era. J Natl Cancer Inst 94(13):958–960

4. Loeb S, Bjurlin MA, Nicholson J et al (2014) Overdiagnosis and overtreatment of prostate cancer. Eur Urol 65(6):1046–1055

5. Wei JT, Dunn RL, Sandler HM et al (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20(2):557–566

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal evaluation of MRI findings, including quantitative apparent diffusion coefficient values, might be necessary to predict disease progression in patients with prostate cancer on active surveillance;World Journal of Urology;2024-03-26